Marc Berger: In the case of tacrolimus for patients receiving lung transplantation, what motivated the FDA to agree that the RWE was sufficient and an RCT not required?

6 Sep 2023

Written by The Evidence Base

Health data Medical devices, pharmaceuticals and vaccines Real-world evidence

In this ‘Patti’s People’ episode, Patti Peeples of the The Peeples Collaborative speaks with Marc Berger, former Pharma Executive and Independent Consultant for real-world data and real-world evidence. View more Patti's People episodes here. Marc Berger Former Pharma Executive and Independent Consultant for real-world data and real-world evidence Marc L. Berger, MD, is a semi-retired, part-time consultant and scientific advisor. Until July 2017, he was Vice President, Real-World Data and Analytics at Pfizer, Inc. Marc has held senior-level positions in industry including Executive Vice President and Senior Scientist at OptumInsight; Vice President, Global Health Outcomes at Eli Lilly and Company;...